LEAP-012 publication

Prof. Vogel is a clinician scientist at the rank of a full professor at the University of Toronto, Canada. He is appointed as the Longo Family Chair in Liver Cancer Research and is leading a multi-pronged research program in basic and clinical science at the Toronto General Hospital and the Princess Margarete Cancer Center. Before joining UNH, he worked as senior consultant at Hannover Medical School for more than 20 years and still holds a research position there. 

Prof. Vogel’s scientific focus is the translational and clinical research in gastrointestinal cancer. Since 2004, he is leading a translational research group interested in the pathogenesis of hepatobiliary cancers and in precision medicine. Arndt Vogel is a clinical investigator in oncology since 2006 and has served as principal investigator on numerous clinical trials. He is author or co-author of more than 330 articles published in peer-reviewed journals including Lancet, Lancet Oncology, Cancer Cell, and Gastroenterology among others. 

Prof. Vogel is member of societies including ESMO, ASCO, and EASL. He is member and chairman of Hepatobiliary Cancer Study Group of the AIO, a collaborative group in clinical oncology in Germany. Within ESMO, he is member of the ESMO Guidelines Steering Committee. He has responsibilities in the establishment of the national guideline and is the coordinator of the ESMO clinical practice guideline on the management of hepatocellular carcinoma and biliary tract cancer.